Clinical research in Japan: Past, present and future

Yuji Sato, Keisuke Koyama

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The volume of clinical research carried out in Japan is relatively small by global standards, especially when compared with the country's contributions to basic research. Although the academic quality of the clinical research done here is generally high, its relative paucity has had a number of alarming consequences, e.g., delays in the approval of important new drugs and medical devices caused by difficulties in clinical trials, leading to the limited availability of novel treatments for Japanese patients. This article aims to present an overview of current clinical research activities in Japan and to summarise the historical, socio-cultural and regulatory issues underlying the current situation. Suggestions are made as to how the present problems might be resolved and how a brighter future for clinical research might be achieved.

Original languageEnglish
Pages (from-to)104-109
Number of pages6
JournalKeio Journal of Medicine
Volume59
Issue number3
Publication statusPublished - 2010 Sep

Fingerprint

Japan
Research
Drug Approval
Clinical Trials
Equipment and Supplies
Therapeutics

Keywords

  • Clinical research
  • Clinical trials
  • Drug lag
  • Research infrastructure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clinical research in Japan : Past, present and future. / Sato, Yuji; Koyama, Keisuke.

In: Keio Journal of Medicine, Vol. 59, No. 3, 09.2010, p. 104-109.

Research output: Contribution to journalArticle

@article{fc2779fbd07b452f960105ef973cf411,
title = "Clinical research in Japan: Past, present and future",
abstract = "The volume of clinical research carried out in Japan is relatively small by global standards, especially when compared with the country's contributions to basic research. Although the academic quality of the clinical research done here is generally high, its relative paucity has had a number of alarming consequences, e.g., delays in the approval of important new drugs and medical devices caused by difficulties in clinical trials, leading to the limited availability of novel treatments for Japanese patients. This article aims to present an overview of current clinical research activities in Japan and to summarise the historical, socio-cultural and regulatory issues underlying the current situation. Suggestions are made as to how the present problems might be resolved and how a brighter future for clinical research might be achieved.",
keywords = "Clinical research, Clinical trials, Drug lag, Research infrastructure",
author = "Yuji Sato and Keisuke Koyama",
year = "2010",
month = "9",
language = "English",
volume = "59",
pages = "104--109",
journal = "Keio Journal of Medicine",
issn = "0022-9717",
publisher = "Keio University School of Medicine",
number = "3",

}

TY - JOUR

T1 - Clinical research in Japan

T2 - Past, present and future

AU - Sato, Yuji

AU - Koyama, Keisuke

PY - 2010/9

Y1 - 2010/9

N2 - The volume of clinical research carried out in Japan is relatively small by global standards, especially when compared with the country's contributions to basic research. Although the academic quality of the clinical research done here is generally high, its relative paucity has had a number of alarming consequences, e.g., delays in the approval of important new drugs and medical devices caused by difficulties in clinical trials, leading to the limited availability of novel treatments for Japanese patients. This article aims to present an overview of current clinical research activities in Japan and to summarise the historical, socio-cultural and regulatory issues underlying the current situation. Suggestions are made as to how the present problems might be resolved and how a brighter future for clinical research might be achieved.

AB - The volume of clinical research carried out in Japan is relatively small by global standards, especially when compared with the country's contributions to basic research. Although the academic quality of the clinical research done here is generally high, its relative paucity has had a number of alarming consequences, e.g., delays in the approval of important new drugs and medical devices caused by difficulties in clinical trials, leading to the limited availability of novel treatments for Japanese patients. This article aims to present an overview of current clinical research activities in Japan and to summarise the historical, socio-cultural and regulatory issues underlying the current situation. Suggestions are made as to how the present problems might be resolved and how a brighter future for clinical research might be achieved.

KW - Clinical research

KW - Clinical trials

KW - Drug lag

KW - Research infrastructure

UR - http://www.scopus.com/inward/record.url?scp=78249279961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249279961&partnerID=8YFLogxK

M3 - Article

C2 - 20881451

AN - SCOPUS:78249279961

VL - 59

SP - 104

EP - 109

JO - Keio Journal of Medicine

JF - Keio Journal of Medicine

SN - 0022-9717

IS - 3

ER -